Etcembly

From Code to Cure: Etcembly combines cutting-edge artificial intelligence and bioengineering to accelerate therapeutic innovation and design next-generation immunotherapies.

Health and bio

Latest funding

Seed · April 23, 2026

Amount not disclosed in a source on record.

Funding history ↓

Website: etcembly.io.

Category: Health and bio.

Stage: Seed.

Last round: Apr 23, 2026 · 203 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredMar 13, 2020 (6 years old)

About Etcembly

Learn how we’re shaping the future of precision medicine.

Funding rounds

April 23, 2026
Seed · amount undisclosed
Source: fundraisingfox.com
March 13, 2020
Website created

Companies like Etcembly

NNanoligent$14.01M Seed · Oct 2025
TTaranis$40M Series B+ · Sep 2022
AAlia Therapeutics$5M Seed · Apr 2023
HHaptena Therapeutics$3.53M Seed · Dec 2025
AAddition Therapeutics$100M Series A · Dec 2025
SSparrow Quantum$32M Series A · Dec 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/etcembly (get a free API key).